[Tocolytic effects of nitric oxide. Introduction to an experimental approach].
Pasquier
J C
JC
Service de gynécologie-obstétrique, Hôpital Edouard-Herriot, Lyon.
D000818:Animals; D004353:Drug Evaluation, Preclinical; D005260:Female; D066298:In Vitro Techniques; D008981:Molsidomine / Q000494:pharmacology; D009569:Nitric Oxide / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000502:physiology; D005996:Nitroglycerin / Q000494:pharmacology; D009599:Nitroprusside / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D015149:Tocolytic Agents / Q000494:pharmacology*; D014590:Uterine Contraction / Q000187:drug effects* / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology
D015149:Tocolytic Agents; D014665:Vasodilator Agents; D009599:Nitroprusside; D009569:Nitric Oxide; D008981:Molsidomine; D019001:Nitric Oxide Synthase; D005996:Nitroglycerin
Les effets tocolytiques du monoxyde d'azote. Introduction à une approche expérimentale.